Alyeska Investment Group
TCON

Alyeska Investment Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Alyeska Investment Group’s Portfolio TCON Stock Details TCON Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$270K Buy
2018
Q1 		$223K Sell
2017
Q4 		$327K Hold
2017
Q3 		$308K Buy
2017
Q2 		$230K Sell
2017
Q1 		$371K Sell
2016
Q4 		$490K Buy